Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce

Fri, 31st Jul 2020 11:28

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - LOSERS

----------

International Consolidated Airlines Group, down 9.4%. Swung to a loss in its first half due to Covid-19 travel restrictions, confirmed a EUR2.75 billion equity raise, and picked a new chair. Revenue for the three months to June 30 was GBP703 million, plunging 89% year-on-year from GBP6.73 billion. Pretax loss for the quarter was GBP2.32 billion, swinging from a profit of GBP921 million. For the six months to June, pretax loss was EUR4.21 billion, swinging from a profit of GBP1.01 billion the year prior. Revenue in the half-year dropped to EUR5.29 billion from GBP12.03 billion. Confirmed plans to raise EUR2.75 billion from a pre-emptive share subscription and largest shareholder Qatar Airways backs proposal. Chair Antonio Vazquez - who reached nine years in office last January - will retire early January 2021. He will be succeeded by Independent Director Javier Ferran.

----------

BT Group, down 3.5%, first quarter earnings suffered from a lack of live sport and the telecommunications firm forecasts a fall in annual revenue. In the three months to June 30, BT's revenue fell 6.8% to GBP5.25 billion and its pretax profit fell 13% to GBP561 million. Forecasts adjusted revenue to fall between 5% and 6%. Adjusted earnings before interest, tax, depreciation and amortisation are expected between GBP7.2 billion and GBP7.5 billion, at best a 5.1% decline. Rob Shuter, outgoing chief executive officer of Johannesburg-listed telecoms firm MTN Group Ltd, is named as the new head of the BT Enterprise business communications unit.

----------

FTSE 250 - WINNERS

----------

Pets At Home, up 15%, total revenue in the first quarter ended July 16 was down 1.0%, but the pet care supplies firm saw like-for-like sales bounce toward the end of the quarter. In the four weeks to June 19, like-for-like sales were up 15%, recovering from a 23% fall in the four weeks to March 27.

----------

FTSE 250 - LOSERS

----------

Petropavlovsk, down 5.7%, 31%-owned investee IRC reports 8.1% quarter-on-quarter improvement in iron ore concentrate production. Sales rise 8.5%. For the first half, Output rose 14% year-on-year, with sales up 12%. On Thursday, proxy advisor recommended Petropavlovsk shareholders vote in favour of the board recommendations of 20% shareholder Prosperity Capital Management and against those of 7.5% holder Everest Alliance Ltd.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Thor Mining, up 31%, reports "visible" gold from samples of Pilbara tenements, Western Australia. "To find visible gold in multiple sites in very close proximity to previous gold samples is very encouraging," notes Executive Chair Mick Billing.

----------

Tiziana Life Sciences PLC up 14%, submits patent application for nasal administration of Foralumab, a potential treatment for Covid-19 patients.

----------

Reneuron Group up 13%, after cell-based therapeutics firm granted a patent by US Patent & Trademark Office. Patent relates to its hRPC cell-based therapeutic candidate aiming to treat retinal diseases.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Coro Energy, down 17%, Asia-focused upstream oil and gas firm reports termination of agreement with Zenith Energy for proposed sale of Coro's Italian portfolio. Coro will continue to "prioritise" the divestment of non-core Italian operations. Zenith shares are down 7.9%

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
29 Aug 2014 05:24

UK AGM, EGM Calendar - Week Ahead

Read more
28 Aug 2014 15:11

UK AGM, EGM Calendar - Week Ahead

Read more
28 Aug 2014 05:31

UK AGM, EGM Calendar - Week Ahead

Read more
27 Aug 2014 15:25

UK AGM, EGM Calendar - Week Ahead

Read more
27 Aug 2014 05:53

UK AGM, EGM Calendar - Week Ahead

Read more
26 Aug 2014 15:16

UK AGM, EGM Calendar - Week Ahead

Read more
25 Jul 2014 09:40

DIRECTOR DEALINGS: ReNeuron Group Directors Buy Shares

Read more
23 Jul 2014 14:17

Sector movers: Weak results, outlook from Glaxo sink pharma stocks

A slump in the share price of GlaxoSmithKline dragged the pharmaceuticals and biotechnology sector into the red on Wednesday as the drugmaker disappointed with a drop in quarterly sales and its full-year outlook. The company announced at midday that it has slashed its 2014 outlook as it reported a

Read more
18 Jun 2014 13:29

ReNeuron well set after 'transformational' year

Stem cell treatment developer ReNeuron lost an increased £7.1m in a "transformational" year to end-March but still had plenty of cash in the bank as it moves into new cell manufacturing facility and files an investigational new drug (IND) application in the US early next year. The AIM-listed compa

Read more
18 Jun 2014 11:47

UK MIDDAY BRIEFING: BOE Policy Makers Still Unanimous

LONDON (Alliance News) - Bank of England policymakers unanimously decided to leave the key interest rates and asset purchase programme unchanged at the monetary policy meeting held on June 4 and 5, the minutes of the meeting showed Wednesday.

All nine members of the Monetary Policy

Read more
18 Jun 2014 08:27

ReNeuron Confident For Future Despite Loss As It Advances Therapies

LONDON (Alliance News) - ReNeuron Group PLC Wednesday expressed confidence in its future as it continued to develop its stem-cell therapies towards commercialisation, and it posted a widened loss in the year to end-March. The company posted a pretax loss of GBP7.8 million, widened from GBP7

Read more
18 Jun 2014 07:21

UK MORNING BRIEFING: Zoopla Prices IPO As Markets Await Central Banks

LONDON (Alliance News) - UK shares have opened higher Wednesday, following a firm close on Wall Street and ahead of central bank announcements in the UK and US.

There was further IPO activity Wednesday, as property website Zoopla Property Group said it will price it

Read more
7 May 2014 14:15

ReNeuron Says Stroke Disability Therapy Study Yielding "Encouraging" Results

LONDON (Alliance News) - Stem cell therapy company ReNeuron Group PLC Wednesday said that its PISCES study of its ReN001 stem cell therapy for stroke disability has continued to yield encouraging results. The company said that there was no cell-related or immunological adverse events report

Read more
23 Apr 2014 12:02

ReNeuron seeks to expand board with new CEO

A new chief executive is being sought by AIM-listed stem cell specialist ReNeuron as it enters the next stage of its development. Current Chief Executive Michael Hunt will remain in the role until a replacement is recruited, when he will become Chief Financial Officer. Chairman Bryan Morton said:

Read more
23 Apr 2014 11:37

ReNeuron Seeking New Chief Executive, Current To Become Financial Officer

LONDON (Alliance News) - ReNeuron Group PLC said Wednesday that it was appointing a new Chief Executive Officer to replace Michael Hunt, who will be moving into the role of Chief Financial Officer when a successor has been recruited. The company said that, as a result of the progress it has

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.